The insulin-producing cells bearing such optogenetic tools could be transplanted into animals after encapsulation in polymer capsules consisting of semi-permeable layers enabling diffusion of nutrients but protecting them from the immune system.55,56 In the future, this strategy could advance treatment of diabetes type I in humans.57,58. Here, INS is linked to type 1 diabetes mellitus.